These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 23038045)
1. Ustekinumab in the treatment of refractory chronic cutaneous lupus erythematosus: a case report. Dahl C; Johansen C; Kragballe K; Olesen AB Acta Derm Venereol; 2013 May; 93(3):368-9. PubMed ID: 23038045 [No Abstract] [Full Text] [Related]
2. Belimumab for refractory manifestations of cutaneous lupus: A multicenter, retrospective observational study of 16 patients. Salle R; Chasset F; Kottler D; Picard-Dahan C; Jannic A; Mekki N; De Risi-Pugliese T; Monfort JB; Barbaud A; Francès C; Descamps V J Am Acad Dermatol; 2020 Dec; 83(6):1816-1819. PubMed ID: 32439463 [No Abstract] [Full Text] [Related]
3. Induction of skin lesions by ultraviolet B irradiation in a case of pemphigus erythematosus. Makino T; Seki Y; Hara H; Mizawa M; Matsui K; Shimizu K; Shimizu T Acta Derm Venereol; 2014 Jul; 94(4):487-8. PubMed ID: 24356850 [No Abstract] [Full Text] [Related]
5. [Cutaneous lupus profundus]. Khalfallah N; Azzabi S; Ben Hassine L; Fathallah L; Kooli C; Fazâa B; Hamza M; Haddad A Tunis Med; 2003 Feb; 81(2):134-9. PubMed ID: 12708181 [TBL] [Abstract][Full Text] [Related]
6. Ustekinumab in severe complicated erythrodermic psoriasis: rapid clearing, safety, and sustained remission. Koutsoukou XA; Papadavid E; Theodoropoulos K; Rigopoulos D Dermatol Ther; 2014; 27(5):257-9. PubMed ID: 24813816 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of adalimumab for the treatment of refractory paediatric acrodermatitis continua of hallopeau. Dini V; Barbanera S; Romanelli M Acta Derm Venereol; 2013 Sep; 93(5):588-9. PubMed ID: 23407925 [No Abstract] [Full Text] [Related]
8. TNF-alpha blockade with infliximab in a patient with lupus erythematosus profundus. Günther C; Aringer M; Lochno M; Kämmerer E; Bauer A; Wozel G; Meurer M Acta Derm Venereol; 2012 Jul; 92(4):401-3. PubMed ID: 22170286 [No Abstract] [Full Text] [Related]
9. [Paclitaxel-induced lupus]. Lortholary A; Cary-Ten Have Dallinga M; El Kouri C; Morineau N; Ramée JF Presse Med; 2007 Sep; 36(9 Pt 1):1207-8. PubMed ID: 17521858 [TBL] [Abstract][Full Text] [Related]
10. Subacute cutaneous lupus erythematosus with melanocyte elimination induced by pembrolizumab. Ogawa-Momohara M; Muro Y; Goto K; Obuse C; Satoh M; Kono M; Akiyama M J Dermatol; 2020 Jun; 47(6):e217-e219. PubMed ID: 32173880 [No Abstract] [Full Text] [Related]
17. Toxic epidermal necrolysis-like cutaneous lupus erythematosus: A series of three patients. Cisneros CG; Romiti R; Santi CG; Aoki V; Valente NY; Nico MM Acta Derm Venereol; 2010 Mar; 90(2):175-8. PubMed ID: 20169302 [TBL] [Abstract][Full Text] [Related]
18. Cutaneous lupus erythematosus induced by golimumab therapy. Al Izzi M; Reda A Int J Rheum Dis; 2017 Dec; 20(12):2159-2161. PubMed ID: 27458030 [No Abstract] [Full Text] [Related]
19. Successful treatment of subacute lupus erythematosus with ustekinumab. De Souza A; Ali-Shaw T; Strober BE; Franks AG Arch Dermatol; 2011 Aug; 147(8):896-8. PubMed ID: 21844448 [No Abstract] [Full Text] [Related]